These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20597086)

  • 1. ROR1 expression is not a unique marker of CLL.
    Barna G; Mihalik R; Timár B; Tömböl J; Csende Z; Sebestyén A; Bödör C; Csernus B; Reiniger L; Peták I; Matolcsy A
    Hematol Oncol; 2011 Mar; 29(1):17-21. PubMed ID: 20597086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
    Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
    Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational modifications regulate signalling by Ror1.
    Kaucká M; Krejčí P; Plevová K; Pavlová S; Procházková J; Janovská P; Valnohová J; Kozubík A; Pospíšilová S; Bryja V
    Acta Physiol (Oxf); 2011 Nov; 203(3):351-62. PubMed ID: 21481194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.
    Daneshmanesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Int J Cancer; 2008 Sep; 123(5):1190-5. PubMed ID: 18546292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
    Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
    Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.
    Dunphy CH; Wheaton SE; Perkins SL
    Mod Pathol; 1997 Aug; 10(8):818-22. PubMed ID: 9267825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.
    Daneshmanesh AH; Porwit A; Hojjat-Farsangi M; Jeddi-Tehrani M; Tamm KP; Grandér D; Lehmann S; Norin S; Shokri F; Rabbani H; Mellstedt H; Österborg A
    Leuk Lymphoma; 2013 Apr; 54(4):843-50. PubMed ID: 22988987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
    Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.
    Baskar S; Kwong KY; Hofer T; Levy JM; Kennedy MG; Lee E; Staudt LM; Wilson WH; Wiestner A; Rader C
    Clin Cancer Res; 2008 Jan; 14(2):396-404. PubMed ID: 18223214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
    J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.
    Daneshmanesh AH; Hojjat-Farsangi M; Khan AS; Jeddi-Tehrani M; Akhondi MM; Bayat AA; Ghods R; Mahmoudi AR; Hadavi R; Österborg A; Shokri F; Rabbani H; Mellstedt H
    Leukemia; 2012 Jun; 26(6):1348-55. PubMed ID: 22289919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
    Hudecek M; Schmitt TM; Baskar S; Lupo-Stanghellini MT; Nishida T; Yamamoto TN; Bleakley M; Turtle CJ; Chang WC; Greisman HA; Wood B; Maloney DG; Jensen MC; Rader C; Riddell SR
    Blood; 2010 Nov; 116(22):4532-41. PubMed ID: 20702778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells.
    Choudhury A; Derkow K; Daneshmanesh AH; Mikaelsson E; Kiaii S; Kokhaei P; Osterborg A; Mellstedt H
    Br J Haematol; 2010 Nov; 151(4):327-35. PubMed ID: 20813009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
    Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
    Int J Cancer; 2008 Sep; 123(5):1025-33. PubMed ID: 18546271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
    Kingma DW; Imus P; Xie XY; Jasper G; Sorbara L; Stewart C; Stetler-Stevenson M
    Cytometry; 2002 Oct; 50(5):243-8. PubMed ID: 12360573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
    Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
    Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.